Release Date: 04/04/11 18:10 Summary: Proposed De-listing and Buy back Price Sensitive: Yes Download Document 39.63KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%